Nonmyeloablative, HLA-haploidentical bone marrow transplantation with high dose, post-transplantation cyclophosphamide

• Κύριοι συγγραφείς: Ashley Munchel (Συγγραφέας), Chimen Kesserwan (Συγγραφέας), Heather J. Symons (Συγγραφέας), Leo Luznik (Συγγραφέας), Yvette L. Kasamon (Συγγραφέας), Richard J. Jones (Συγγραφέας), Ephraim J. Fuchs (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: MDPI AG, 2011-06-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Allogeneic stem cell transplantation (SCT) from an HLA-haploidentical relative provides a potentially curative treatment option for hematologic malignancies patients who lack a suitably HLA-matched donor. The greatest challenge to performing HLA-haploidentical SCT has been high rates of graft failur...